Status:
RECRUITING
Morehouse Total Cancer Care Protocol
Lead Sponsor:
Morehouse School of Medicine
Conditions:
Cancer
Cancer Risk
Eligibility:
All Genders
18+ years
Brief Summary
The overall objective of the Morehouse Total Cancer Care study is to develop an improved standard of cancer care by facilitating new biomarker and drug target discovery, informatics solutions, clinica...
Detailed Description
Through this protocol, Morehouse School of Medicine and its partners will establish and maintain a unique repository of blood, tissue, other biological samples and their associated data (survey data, ...
Eligibility Criteria
Inclusion
- 18 years of age and older.
- Diagnosed with cancer, or at risk for cancer. This includes anyone in the general population, but our primary focus will be on patients with a cancer diagnosis.
- Able to understand and sign the TCCP Informed Consent and Research Authorization form directly or through an authorized representative. The Informed Consent and Research Authorization will be available in both English and Spanish languages
Exclusion
- None
- \-
Key Trial Info
Start Date :
April 5 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2037
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT04804878
Start Date
April 5 2018
End Date
April 1 2037
Last Update
March 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Morehouse School of Medicine
Atlanta, Georgia, United States, 30310